Abstract
Little is known about genetics of heart failure with preserved ejection fraction (HFpEF) in part because of the many comorbidities in this population. To identify single-nucleotide polymorphisms (SNPs) associated with HFpEF, we analyzed phenotypic and genotypic data from the Cardiovascular Health Study, which profiled patients using a 50,000 SNP array. Results were explored using novel SNP- and gene-centric tools. We performed analyses to determine whether some SNPs were relevant only in certain phenotypes. Among 3804 patients, 7 clinical factors and 9 SNPs were significantly associated with HFpEF; the most notable of which was rs6996224, a SNP associated with transforming growth factor-beta receptor 3. Most SNPs were associated with HFpEF only in the absence of a clinical predictor. Significant SNPs represented genes involved in myocyte proliferation, transforming growth factor-beta/erbB signaling, and extracellular matrix formation. These findings suggest that genetic factors may be more important in some phenotypes than others.
Similar content being viewed by others
Abbreviations
- AF:
-
Atrial fibrillation
- BMI:
-
Body mass index
- CAD:
-
Coronary artery disease
- CHS:
-
Cardiovascular Health Study
- CKD:
-
Chronic kidney disease
- COPD:
-
Chronic obstructive pulmonary disease
- DM:
-
Diabetes mellitus
- GWA:
-
Genome-wide association
- HFpEF:
-
Heart failure with preserved ejection fraction
- IBC:
-
ITMAT-Broad-CARe
- HTN:
-
Hypertension
- OR:
-
Odds ratio
- SNP:
-
Single-nucleotide polymorphism
- TGF:
-
Transforming growth factor
References
Senni, M., Paulus, W. J., Gavazzi, A., Fraser, A. G., Díez, J., Solomon, S. D., Smiseth, O. A., Guazzi, M., Lam, C. S., et al. (2014). New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes. European Heart Journal, 35(40), 2797–2815.
Shah, S. J., Katz, D. H., & Deo, R. C. (2014). Phenotypic spectrum of heart failure with preserved ejection fraction. Heart Failure Clinics, 10(3), 407–418.
Vazir, A., & Solomon, S. D. (2014). Management strategies for heart failure with preserved ejection fraction. Heart Failure Clinics, 10(4), 591–598.
Borlaug, B. A., & Paulus, W. J. (2011). Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. European Heart Journal, 32(6), 670–679.
Kao, D. P., Lewsey, J. D., Anand, I. S., Massie, B. M., Zile, M. R., Carson, P. E., McKelvie, R. S., Komajda, M., McMurray, J. J., & Lindenfeld, J. (2015). Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response. European Journal of Heart Failure, 17(9), 925–935.
Shah, S. J., Katz, D. H., Selvaraj, S., Burke, M. A., Yancy, C. W., Gheorghiade, M., Bonow, R. O., Huang, C. C., & Deo, R. C. (2015). Phenomapping for novel classification of heart failure with preserved ejection fraction. Circulation, 131(3), 269–279.
Fried, L. P., Borhani, N. O., Enright, P., Furberg, C. D., Gardin, J. M., Kronmal, R. A., Kuller, L. H., Manolio, T. A., Mittelmark, M. B., & Newman, A. (1991). The cardiovascular health study: design and rationale. Annals of Epidemiology, 1(3), 263–276.
Mailman, M. D., Feolo, M., Jin, Y., Kimura, M., Tryka, K., Bagoutdinov, R., Hao, L., Kiang, A., Paschall, J., et al. (2007). The NCBI dbGaP database of genotypes and phenotypes. Nature Genetics, 39(10), 1181–1186.
Gardin, J. M., Wong, N. D., Bommer, W., Klopfenstein, H. S., Smith, V. E., Tabatznik, B., Siscovick, D., Lobodzinski, S., Anton-Culver, H., & Manolio, T. A. (1992). Echocardiographic design of a multicenter investigation of free-living elderly subjects: the cardiovascular health study. Journal of the American Society of Echocardiography, 5(1), 63–72.
Ives, D. G., Fitzpatrick, A. L., Bild, D. E., Psaty, B. M., Kuller, L. H., Crowley, P. M., Cruise, R. G., & Theroux, S. (1995). Surveillance and ascertainment of cardiovascular events. The cardiovascular health study. Annals of Epidemiology, 5(4), 278–285.
Gottdiener, J. S., McClelland, R. L., Marshall, R., Shemanski, L., Furberg, C. D., Kitzman, D. W., Cushman, M., Polak, J., Gardin, J. M., et al. (2002). Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The cardiovascular health study. Annals of Internal Medicine, 137(8), 631–639.
Mentz, R. J., Kelly, J. P., von Lueder, T. G., Voors, A. A., Lam, C. S., Cowie, M. R., Kjeldsen, K., Jankowska, E. A., Atar, D., et al. (2014). Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction. Journal of the American College of Cardiology, 64(21), 2281–2293.
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. L., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., & Greene, T. (2009). A new equation to estimate glomerular filtration rate. Annals of Internal Medicine, 150(9), 604–612.
Keating, B. J., Tischfield, S., Murray, S. S., Bhangale, T., Price, T. S., Glessner, J. T., Galver, L., Barrett, J. C., Grant, S. F., et al. (2008). Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies. PloS One, 3(10), e3583.
Chang, C. C., Chow, C. C., Tellier, L. C., Vattikuti, S., Purcell, S. M., & Lee, J. J. (2015). Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience, 4, 7.
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A., Bender, D., Maller, J., Sklar, P., de Bakker, P. I., et al. (2007). PLINK: a tool set for whole-genome association and population-based linkage analyses. American Journal of Human Genetics, 81(3), 559–575.
Sherry, S. T., Ward, M. H., Kholodov, M., Baker, J., Phan, L., Smigielski, E. M., & Sirotkin, K. (2001). dbSNP: the NCBI database of genetic variation. Nucleic Acids Research, 29(1), 308–311.
International HapMap Consortium. (2003). The international HapMap project. Nature, 426(6968), 789–796.
Whirl-Carrillo, M., McDonagh, E. M., Hebert, J. M., Gong, L., Sangkuhl, K., Thorn, C. F., Altman, R. B., & Klein, T. E. (2012). Pharmacogenomics knowledge for personalized medicine. Clinical Pharmacology and Therapeutics, 92(4), 414–417.
Leach, S. M., Tipney, H., Feng, W., Baumgartner, W. A., Kasliwal, P., Schuyler, R. P., Williams, T., Spritz, R. A., & Hunter, L. (2009). Biomedical discovery acceleration, with applications to craniofacial development. PLoS Computational Biology, 5(3), e1000215.
Vehlow, C., Kao, D. P., Bristow, M. R., Hunter, L. E., Weiskopf, D., & Görg, C. (2015). Visual analysis of biological data-knowledge networks. BMC Bioinformatics, 16(1), 135.
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003). Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Research, 13(11), 2498–2504.
Ho, J. E., Lyass, A., Lee, D. S., Vasan, R. S., Kannel, W. B., Larson, M. G., & Levy, D. (2012). Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction. Circulation Heart Failure, 6(2), 279–286.
Huang, D. A. W., Sherman, B. T., & Lempicki, R. A. (2009). Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protocols, 4(1), 44–57.
Gene Ontology Consortium. (2015). Gene ontology consortium: going forward. Nucleic Acids Research, 43(Database issue), D1049–D1056.
Kanehisa, M., & Goto, S. (2000). KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Research, 28(1), 27–30.
Huntgeburth, M., Tiemann, K., Shahverdyan, R., Schlüter, K. D., Schreckenberg, R., Gross, M. L., Mödersheim, S., Caglayan, E., Müller-Ehmsen, J., et al. (2011). Transforming growth factor β1 oppositely regulates the hypertrophic and contractile response to β-adrenergic stimulation in the heart. PloS One, 6(11), e26628.
Lou, J., Zhao, D., Zhang, L. L., Song, S. Y., Li, Y. C., Sun, F., Ding, X. Q., Yu, C. J., Li, Y. Y., et al. (2016). Type III transforming growth factor-β receptor drives cardiac hypertrophy through β-arrestin2-dependent activation of calmodulin-dependent protein kinase II. Hypertension, 68(3), 654–666.
Deten, A., Hölzl, A., Leicht, M., Barth, W., & Zimmer, H. G. (2001). Changes in extracellular matrix and in transforming growth factor beta isoforms after coronary artery ligation in rats. Journal of Molecular and Cellular Cardiology, 33(6), 1191–1207.
Chu, W., Li, X., Li, C., Wan, L., Shi, H., Song, X., Liu, X., Chen, X., Zhang, C., et al. (2011). TGFBR3, a potential negative regulator of TGF-β signaling, protects cardiac fibroblasts from hypoxia-induced apoptosis. Journal of Cellular Physiology, 226(10), 2586–2594.
Sun, F., Duan, W., Zhang, Y., Zhang, L., Qile, M., Liu, Z., Qiu, F., Zhao, D., Lu, Y., & Chu, W. (2015). Simvastatin alleviates cardiac fibrosis induced by infarction via up-regulation of TGF-β receptor III expression. British Journal of Pharmacology, 172(15), 3779–3792.
Hermida, N., López, B., González, A., Dotor, J., Lasarte, J. J., Sarobe, P., Borrás-Cuesta, F., & Díez, J. (2009). A synthetic peptide from transforming growth factor-beta1 type III receptor prevents myocardial fibrosis in spontaneously hypertensive rats. Cardiovascular Research, 81(3), 601–609.
Hu, B. C., Li, L., Sun, R. H., Gao, P. J., Zhu, D. L., Wang, J. G., & Chu, S. L. (2010). The association between transforming growth factor beta3 polymorphisms and left ventricular structure in hypertensive subjects. Clinica Chimica Acta, 411(7–8), 558–562.
Mujumdar, V. S., & Tyagi, S. C. (1999). Temporal regulation of extracellular matrix components in transition from compensatory hypertrophy to decompensatory heart failure. Journal of Hypertension, 17(2), 261–270.
Mizuno, T., Yau, T. M., Weisel, R. D., Kiani, C. G., & Li, R. K. (2005). Elastin stabilizes an infarct and preserves ventricular function. Circulation, 112(9 Suppl), I81–I88.
Liu, X., Gu, X., Li, Z., Li, X., Li, H., Chang, J., Chen, P., Jin, J., Xi, B., et al. (2006). Neuregulin-1/erbB-activation improves cardiac function and survival in models of ischemic, dilated, and viral cardiomyopathy. Journal of the American College of Cardiology, 48(7), 1438–1447.
Lemmens, K., Doggen, K., & De Keulenaer, G. W. (2007). Role of neuregulin-1/ErbB signaling in cardiovascular physiology and disease: implications for therapy of heart failure. Circulation, 116(8), 954–960.
Gui, C., Zhu, L., Hu, M., Lei, L., & Long, Q. (2012). Neuregulin-1/ErbB signaling is impaired in the rat model of diabetic cardiomyopathy. Cardiovascular Pathology, 21(5), 414–420.
Biernacka, A., Cavalera, M., Wang, J., Russo, I., Shinde, A., Kong, P., Gonzalez-Quesada, C., Rai, V., Dobaczewski, M., Lee, D., Wang, X., & Frangogiannis, N. (2015). Smad3 signaling promostes fibrosis while preserving cardiac and aortic geometry in obese diabetic mice. Circulation Heart Failure, 8(4), 788–798.
Falcão-Pires, I., & Leite-Moreira, A. (2012). Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment. Heart Failure Reviews 17(3), 325–344.
Paulus, W. J., & Tschöpe, C. (2013). A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. Journal of the American College of Cardiology, 62(4), 263–271.
Glezeva, N., & Baugh, J. A. (2014). Role of inflammation in the pathogenesis of heart failure with preserved ejection fraction and its potential as a therapeutic target. Heart Failure Reviews, 19(5), 681–694.
Buglioni, A., & Burnett, J. C. (2015). Pathophysiology and the cardiorenal connection in heart failure. Circulating hormones: biomarkers or mediators. Clinica Chimica Acta, 443, 3–8.
Acknowledgements
The authors would like to thank William Baumgartner for his role in creating the gene-centric knowledge networks for this analysis.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Sources of Funding
This work was supported the American Heart Association Cardiovascular Phenome-Genome Study Award 15CVGPSD27090024.
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Associate Editor Sanjiv Shah oversaw the review of this article
Rights and permissions
About this article
Cite this article
Kao, D.P., Stevens, L.M., Hinterberg, M.A. et al. Phenotype-Specific Association of Single-Nucleotide Polymorphisms with Heart Failure and Preserved Ejection Fraction: a Genome-Wide Association Analysis of the Cardiovascular Health Study. J. of Cardiovasc. Trans. Res. 10, 285–294 (2017). https://doi.org/10.1007/s12265-017-9729-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12265-017-9729-1